Saniona’s drug candidate could expand Jazz Pharmaceuticals portfolio in epilepsy. But this preclinical small molecule will need to show advantages in safety and efficacy to compete with Biohaven Pharmaceuticals and Xenon Pharmaceuticals, each with clinical-stage drugs that hit the same epilepsy target. The post Jazz Pharma Broadens Its Prospects in Epilepsy With Deal for Selective…
[Sponsored] A one-size fits most approach to clinical trial recruitment is no longer effective. A webinar discussion emphasized the need for patient-level data to shape each phase of a drug’s lifecycle, from clinical development to market access. The post How Can RWD Transform the Patient Journey? appeared first on MedCity News.
Todo comenzó con un curso de mecanografía en la escuela secundaria. Wanda Woods se matriculó porque su padre le dijo que dominar la mecanografía le ayudaría a encontrar trabajo. Y así fue, la Agencia de Protección Ambiental (EPA) federal la contrató como trabajadora extraescolar cuando estaba cursando el onceavo grado. El supervisor “me sentó delante…
To inform future directions for PEPFAR and other U.S. global health programs, this policy brief reviews the graduation policies of several institutions to identify options for consideration.
Sean Bell is head of new ventures at Spring Health, a very well-funded mental health company. They’ve built a tech platform that its providers (both contractors and FT employees) are on, and spend a lot of time using machine learning to match patients to therapists, to augment the care and also measure the impact of…
As bird flu continues to spread among animals in the U.S., KFF’s Tracking Poll on Health Information and Trust finds that the public is more concerned about its impact on food prices than potential health impacts. Trust in the CDC to provide information on bird flu is also divided along partisan lines, and a large…
Rebecca Kasen has seen and heard things in recent years in and around Michigan’s capital city that she never would have expected. “It’s a very weird time in our lives,” said Kasen, executive director of the Women’s Center of Greater Lansing. Last November, a group of people were captured on surveillance video early one morning…
For the most part, Keyanna Jones and her husband thought they knew what to expect when their daughter Chloë had eye surgery last fall. Even Chloë, who was in kindergarten, had a good understanding of how things would go that day. Before the procedure, a hospital worker gave her a coloring book that explained the…
A very small percentage of health outcomes are tied to direct healthcare activities. The non-medical factors, conditions in which people are born, grow, live, and work in, more often than not, impact health outcomes more than the clinical care they receive. The post A Reality Check on SDOH: Challenges We Can’t Ignore appeared first on…
PepGen is one of several companies vying to bring to market the first treatment for the rare muscle disorder myotonic dystrophy type 1, or DM1. Preliminary Phase 1 data indicate its drug candidate is competitive with others further ahead in development. The post PepGen Drug Shows Signs of Topping Rivals in Rare Muscle Disease With…